MedJ

🔴China's leading medical media | 3M+ HCPs, 10M+ subscribers | For global clinicians & researchers tracking China

[MedJ @MedJ0401]

2026 Taishan Award has added AI-assisted nominations, blinded peer review for two categories and a four-tier process to its no-application model. Could auditable review strengthen trust in expert-led medical awards without reducing merit to metrics?

[MedJ @MedJ0401]

Read more: https://t.co/IfX2IBTYjC

[MedJ @MedJ0401]

Prof. Yilong Wu’s team at Guangdong Provincial People’s Hospital has 8 studies lined up for WCLC 2026 in Seoul, exploring how imaging, immune biomarkers and perioperative therapy could refine lung cancer care. Full article below.

[MedJ @MedJ0401]

Read more: https://t.co/bg1EWixyJ2

[MedJ @MedJ0401]

Prof. Li Zhang of Sun Yat-sen University Cancer Center will present a phase 3 trial of B7-H3 ADC Tam-Peli versus topotecan in relapsed small-cell lung cancer at WCLC 2026. Results are pending—a key study to watch among the center's 8 reports. Full article below.

[MedJ @MedJ0401]

Read more: https://t.co/E1m7phAUl9

[MedJ @MedJ0401]

Two Chinese phase 3 trials take B7-H3 ADCs to the WCLC 2026 Presidential Symposium: TAISHAN-302 and ARTEMIS-008 compare them with topotecan in relapsed SCLC. The focus: overall survival and safety, beyond early response rates. Full article below.

[MedJ @MedJ0401]

Read more: https://t.co/wdsCWFjgmt

[MedJ @MedJ0401]

Prof. Jieming Qu's team at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine @sjtu1896 , presented 12 studies at ERS 2026: AI-based respiratory assessment, lung regeneration and bronchiectasis treatment among the key themes. Full article below.

[MedJ @MedJ0401]

Read more: https://t.co/iJzo13A1of

[MedJ @MedJ0401]

In uncontrolled asthma, BGF triple therapy improved lung function with and without persistent airflow limitation, MedJ reports from a KALOS/LOGOS post-hoc analysis. Week-24 trough FEV1 gains vs budesonide/formoterol: 92 mL and 57 mL, respectively. Full article below.

[MedJ @MedJ0401]

Read more: https://t.co/lMLnKQTzwP

[MedJ @MedJ0401]

Patients helped shape around 90 sessions at ERS 2026 in Barcelona, putting partnership at the heart of respiratory medicine. Next stop: Milan, 11–14 September 2027, with prevention and early detection in focus. Full article below.

[MedJ @MedJ0401]

Read More: https://t.co/jN1WAjPH2d

[MedJ @MedJ0401]

ERS 2026 Best Assembly Abstract Awards went to Dr. Sisi Dai and Dr. Hong Luo of West China Hospital
@IHuaXi , Sichuan University @SCUCN , for research on lung cancer immune responses and COPD–tuberculosis comorbidity across 204 countries and territories. Full article below.

[MedJ @MedJ0401]

Read more: https://t.co/T8neuseUwj

[MedJ @MedJ0401]

Patients as partners in respiratory care and research: ERS 2026 in Barcelona put this into practice, with patient representatives co-chairing over 30 sessions and 46 sessions featuring patients and carers as speakers. Full article below.

[MedJ @MedJ0401]

Read more: https://t.co/e4zDEc6iql

[MedJ @MedJ0401]

ERS 2026: Six China-based researchers received Best Abstract Grants in Assembly. Among them, Hong Luo and Sisi Dai of West China Hospital, Sichuan University, studied COPD–TB patterns and immune responses in lung cancer, respectively. Full article below.

[MedJ @MedJ0401]

Read more: https://t.co/iONbhAH7Ju

[MedJ @MedJ0401]

Prof. Bin Cao of China-Japan Friendship Hospital and Prof. Kian Fan Chung of Imperial College London @imperialcollege co-chaired ERS 2026 China Day, bringing Chinese and European perspectives to ARDS, sleep medicine and bronchoscopic lung cancer ablation, including evidence gaps shaping future research. Full article below.